Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
32°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Jasper Therapeutics, Inc. - Class A Common Stock
(NQ:
JSPR
)
22.36
-0.14 (-0.60%)
Streaming Delayed Price
Updated: 10:14 AM EST, Dec 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jasper Therapeutics, Inc. - Class A Common Stock
< Previous
1
2
3
4
Next >
$20 Million Bet On Precigen? Check Out These 4 Penny Stocks Insiders Are Buying
February 01, 2023
The Dow Jones jumped more than 350 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 13, 2023
Via
Benzinga
Why Is Jasper Therapeutics (JSPR) Stock Up 50% Today?
January 13, 2023
JSPR stock is shooting higher as Jasper Therapeutics helps to combat the life-threatening impact of certain blood diseases.
Via
InvestorPlace
Jasper Therapeutics Announces Development Prioritization of Briquilimab In Chronic Diseases
January 10, 2023
Via
Benzinga
Jasper Therapeutics Shares Jump After Positive Data From Sickle Cell Disease Trial
January 03, 2023
Via
Benzinga
APRN Stock Alert: Short Squeeze Takes Blue Apron Back Above $1
January 13, 2023
Blue Apron (APRN) stock has investors excited on Friday as the company's shares increased above the $1 NYSE minimum requirement.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
January 13, 2023
Via
Benzinga
AVCT Stock Alert: Is American Virtual Cloud the Next Big Squeeze?
January 13, 2023
American Virtual Cloud Technologies (AVCT) stock is on the minds of traders with some wondering what's next for the company.
Via
InvestorPlace
Jasper Therapeutics Trade Higher As New Briquilimab Data Shows Safety, Efficacy In Blood Cancer Patients
January 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 13, 2023
Via
Benzinga
Why Jasper Therapeutics Shares Are Popping Off Today
January 10, 2023
Jasper Therapeutics Inc (NASDAQ: JSPR) shares are trading higher by 13.21% to $1.80 Tuesday morning after the company announced development prioritization of briquilimab in chronic diseases and stem...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 10, 2023
Via
Benzinga
Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
January 05, 2023
Gainers Vyant Bio, Inc. (NASDAQ: VYNT) shares rose 110.4% to $1.62 in pre-market trading after the company said it has engaged LifeSci Capital as its advisor to explore strategic alternatives.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 05, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers for Thursday that traders need to know about!
Via
InvestorPlace
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 04, 2023
Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2023
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 04, 2023
Via
Benzinga
Why Oblong Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket
January 04, 2023
Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares rose 63.2% to $0.4201 in pre-market trading after dropping 8% on Tuesday. Elys Game Technology and Cloakbook were recently granted a license to...
Via
Benzinga
Nasdaq Down 1%; Crude Oil Falls Sharply
January 03, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Tuesday.
Via
Benzinga
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 03, 2023
Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 03, 2023
Via
Benzinga
US Stocks Turn Lower; Dow Falls 100 Points
January 03, 2023
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 100 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 29, 2022
Via
Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
December 29, 2022
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.